Skip to main content
. 2019 Oct 22;2019(10):CD005015. doi: 10.1002/14651858.CD005015.pub4

Ugur 2000.

Methods
  • Study design: parallel RCT

  • Duration of study: 1985 to 1999

  • Duration of follow‐up: 12 months

Participants
  • Country: Turkey

  • Setting: single centre

  • Inclusion criteria: adult kidney transplant recipients

  • Number: 45 (numbers not reported for the groups)

  • Age range: 18 to 46 years (ages not reported for the groups)

  • Sex (M/F): 29/16 (not reported for the groups)

  • Exclusion criteria: not reported

Interventions Treatment group 1
  • Calcium carbonate: 3 g/d

  • Calcitriol: 0.5 µg/d


Treatment group 2
  • Calcium: 3 g/d

  • Calcitriol: 0.5 µg/d

  • Calcitonin (nasal): 200 IU/ alternate days for 6 months; stopped for 3 months then recommenced


Treatment group 3
  • Calcium: 3 g/d


Control group
  • No treatment


Co‐interventions
  • Not reported

Outcomes
  • BMD by DEXA at lumbar spine and femoral neck

Notes
  • Funding source: not reported

  • Trial registration: not applicable as published before end of 2005

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Insufficient information to permit judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Unblinded study
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Insufficient information to permit judgement
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Insufficient information to permit judgement
Selective reporting (reporting bias) High risk Patient‐centred outcomes not reported systematically
Other bias Unclear risk Insufficient information to permit judgement